appropriate therapy is curative in some disorders Analysis of cerebrospinal fluid neurotransmitter levels aids identification of the specific monoamine pathway defect and is vital for accurate diagnosis of most primary neurotransmitter disorders and selection of appropriate disease-specific pharmacotherapy Research in the past few years has identified novel monoamine neurotransmitter disorders that involve defects in dopamine transport and monoamine vesicle packaging Discoveries of novel genetic defects and biomarkers in monoamine neurotransmitter disorders, together with novel disease models, will improve our understanding of pathophysiological mechanisms and facilitate the development of new treatments Abstract The monoamine neurotransmitter disorders are important genetic syndromes that cause disturbances in catecholamine (dopamine, noradrenaline and adrenaline) and serotonin homeostasis
For glutathione and glutamate quantification, cell viability analysis and oxidative stress assay, cells were sub-cultured in 12-well plates at a density of 4.2 10 5 cells/well
Off-label uses: In some cases, it may be prescribed for weight management
its about ensuring that a researcher in a molecular biology lab can rely on the molar mass and peptide content specified on the label
To further assess the additive effects of bilateral versus unilateral T-RDN on GLP-1 mediated hemodynamic changes remains to be examined
In gut endocrine cells, proglucagon is processed to glicentin, oxyntomodulin, GLP-1 and GLP-2, all of which have biological activity (28)
